3D-printed heart valve models have the feel and look of the real thing Image courtesy McAlpine Group/University of Minnesota The patient-specific models were designed to help clinicians prepare for transcatheter aortic valve replacement (TAVR) procedures. Read more about 3D-printed heart valve models have the feel and look of the real thing
A winning strategy for blood transfusions among anemic heart attack patients Researchers detailed a method that improves patient safety and leads to significant cost savings.Read more about A winning strategy for blood transfusions among anemic heart attack patients
Confirmed: Key heart medications safe to use for COVID-19 patients The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.Read more about Confirmed: Key heart medications safe to use for COVID-19 patients
Researchers share praise—and concerns—about how the keto diet and intermittent fasting affect cardiovascular health Learn what the experts had to say about these two popular diets.Read more about Researchers share praise—and concerns—about how the keto diet and intermittent fasting affect cardiovascular health
Why early rhythm control therapy is so important for atrial fibrillation patients The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.Read more about Why early rhythm control therapy is so important for atrial fibrillation patients
Shear wave imaging ‘extremely promising’ for assessment of myocardial stiffness in heart transplant recipients The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.Read more about Shear wave imaging ‘extremely promising’ for assessment of myocardial stiffness in heart transplant recipients
Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less. Read more about Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients
New breathing device for COVID-19 patients, co-developed by a cardiologist, gains key patent The device delivers helium and oxygen to the user while capturing exhaled gas in a closed-off “rebreather” system. Read more about New breathing device for COVID-19 patients, co-developed by a cardiologist, gains key patent
AFib rates continue to rise, especially among older patientsThe study's authors tracked EHR data of more than 500,000 patients from a single health system in Pennsylvania. Read more about AFib rates continue to rise, especially among older patients
How to predict a CVD patient’s risk of total, colorectal and lung cancer The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.Read more about How to predict a CVD patient’s risk of total, colorectal and lung cancer
